About this policy
The comment period for the MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma Local Coverage Determination (LCD) began on 06/08/2023 and ended on 07/22/2023. The notice period for L39585 begins on 07/04/2024 and will become effective on 08/18/2024. The comments below were received from the provider community.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.